drugset / Trial / NCT02010918

Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis

NCT02010918

Phase 3 Completed 922 enrolled Ache Laboratorios Farmaceuticos S.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether 500 mg Glucosamine Sulfate / 400 mg Chondroitin Sulfate Capsules and 1500 mg Glucosamine Sulfate / 1200 mg Chondroitin Sulfate Sachet is effective and safe compared Cosamin DS ® Capsule in Treatment of Knee Osteoarthritis.

Timeline

Start
2009-02
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin sulfate Unknown 400 mg
Subject Chondroitin sulfate Unknown 1200 mg
Subject Glucosamine Small molecule 500 mg
Subject Glucosamine Small molecule 1500 mg

Indications